Increased risks of autoimmune rheumatic diseases in patients with psoriasis: A nationwide population-based study - 19/09/18
Doi : 10.1016/j.jaad.2018.06.026
Hyun Jeong Ju, MD a, b, Ki-Jo Kim, MD, PhD c, Dae Suk Kim, MD, PhD d, Ji Hae Lee, MD, PhD a, Gyung Moon Kim, MD, PhD a, Chul Jong Park, MD, PhD b, ⁎ 
, Jung Min Bae, MD, PhD a, ⁎
, Jung Min Bae, MD, PhD a, ⁎ a Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
b Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea
c Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
d Yonsei Young Skin Clinic, Seoul, Korea
∗Reprint requests: Jung Min Bae, MD, PhD, Department of Dermatology, St. Vincent's Hospital, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea.Department of DermatologySt. Vincent's HospitalThe Catholic University of Korea93 Jungbu-daero, Paldal-guSuwon16247Korea∗Reprint requests: Chul Jong Park, MD, PhD, Department of Dermatology, Bucheon St. Mary's Hospital, The Catholic University of Korea, 327 Sosa-ro, Wonmi-gu, Bucheon 14647, KoreaDepartment of DermatologyBucheon St. Mary's HospitalThe Catholic University of Korea327 Sosa-ro, Wonmi-guBucheon14647Korea
| Funding sources: Supported by the Ministry of Science, ICT and Future Panning (grant NRF-2017R1E1A1A01076780). |
|
| Conflicts of interest: None disclosed. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 4
P. 778-781 - octobre 2018 Retour au numéro
Article précédent
- Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR (“Research on Adverse Drug events And Reports”) program
- Kelsey A. Orrell, Morgan Murphrey, Ryan C. Kelm, Harrison H. Lee, David R. Pease, Anne E. Laumann, Dennis P. West, Beatrice Nardone
- The case of the dog and the blue light
- Daniel A. Grabell, Adelaide A. Hebert
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?